Clinical Oncology Online: Access to Continually Updated Online

· Features the addition of basic science editor Michael B. Kastan, MD, PhD, ensuring complete coverage of essential scientific topics.· Discusses the latest advances, including the most current developments in stem cell therapies and new approaches to innovations in diagnosis.· Provides new information on geriatric oncology, as well as new chapters on pathology, imaging, and molecularly targeted therapies.· Covers the hottest topics in the field, such as molecular tools in cancer research, cellular microenvironment, stem cells in cancer susceptibility genes, and more.· Presents a multidisciplinary approach to disease chapters, including a pathologist, radiation oncologist, medical oncologist, and surgeon.· Incorporates the text with a state-of-the-art, dedicated website...featuring fully searchable contents of the 3rd Edition.· Includes all of the artwork from the text plus additional images downloadable into PowerPoint® presentations.· Features weekly content updates.Purchase of this product includes a limited personal license for use exclusively by the individual who has purchased the product. This license and access to the web site operates strictly on the basis of a single user per PIN. The sharing of passwords is strictly prohibited, and any attempt to do so will invalidate the password. The license and access may not be lent, resold, or otherwise circulated. Full details of the license and terms and conditions of use are available upon registration.Your purchase of Clinical Oncology Online, 3rd Edition entitles you to access the web site until the next edition is published, or until the current edition is no longer offered for sale by Elsevier, whichever occurs first. If the next edition is published less than one year after your purchase, you will be entitled to online access for one year from your date of purchase. Elsevier reserves the right to offer a suitable replacement product (such as a downloadable or CD-ROM-based electronic version) should online access to the web site be discontinued.